FGFR inhibitors and methods of use thereof
US11780845B2 · kind B2 · utility
0Cited by
4References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 31, 2023 |
| Grant date | Oct 10, 2023 |
| Priority date | — |
| Expiry date | Jan 31, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel compounds and pharmaceutical compositions thereof, and methods for inhibiting the activity of FGFR enzymes with the compounds and compositions of the disclosure. The present disclosure further relates to, but is not limited to, methods for treating disorders associated with FGFR signaling with the compounds and compositions of the disclosure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.